Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
iron dextran (INFeD) (1 trial)
alpha-lipoic acid (1 trial)
Polyneuropathies (Phase 2)
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (Phase 2)
Trials (2 total)
Trial APIs (2 total)